Food and Drug Administration Procedures for New Drug and Device Approvals

Am J Ophthalmol. 2016 Jan:161:1-3. doi: 10.1016/j.ajo.2015.11.022.

¹ Ocular Inflammatory Disease Center, UCLA Stein Eye Institute and the Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California. Electronic address: [email protected].
² Division of Ophthalmic and Ear, Nose, and Throat Devices, Office of Device Evaluation, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland.
³ Division of Transplant & Ophthalmology Products, Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.

No abstract available

Publication types